Psoriasis is a chronic disease affecting over 125 million people all over the world and an increasing trend has been observed [1,2]. As a systemic inflammatory process, it predisposes, twice as frequently than in the general population, to the development of metabolic disorders (insulin resistance, atherogenic dyslipidemia, arterial hypertension, and cardio-vascular diseases) and, consequently, to life shortening.

[pdf-embedder url=”https://www.nsorm.com/wp-content/uploads/2018/07/Stem-Cells-in-the-Tx-of-Psoriasis-Oct-2017.pdf” title=”Stem Cells in the Tx of Psoriasis Oct 2017″]